The Chicago Entrepreneur

The Wall Street Journal: Amgen reportedly in talks to buy Horizon Therapeutics

The U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon, according to sources cited by The Wall Street Journal.

Previous post Inflation has peaked — but it’s not returning to pre-Covid levels in 2023, Mastercard says
Next post Rivian pauses plans to make electric vans in Europe with Mercedes-Benz